ProfileGDS4177 / 214684_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 87% 85% 90% 88% 82% 81% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated366.9387
GSM603099KU-812 non-treated328.3585
GSM603098KCL-22 Imatinib-treated494.0490
GSM603097KCL-22 non-treated429.4988
GSM603102JURL-MK1 Imatinib-treated249.2382
GSM603101JURL-MK1 non-treated220.681